COVIDonneur - SARS-CoV-2 seroprevalence study in the blood donor population
Head :
Gallian Pierre, Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille
Last update : 05/06/2021 | Version : 1 | ID : 73556
| General | |
| Identification | |
| Detailed name | SARS-CoV-2 seroprevalence study in the blood donor population |
| Sign or acronym | COVIDonneur |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | dossier RIPH : 20.04.28.41321 |
| General Aspects | |
| Medical area |
Infectious diseases |
| Study in connection with Covid-19 |
Yes |
| Keywords | blood donors, serology prevalence, SARS-CoV-2 |
| Scientific investigator(s) (Contact) | |
| Name of the director | Gallian |
| Surname | Pierre |
| Address | Etablissement Français du Sang, 20 avenue du Stade de France, 93128 La Plaine Saint Denis |
| Unit | Emerging Viruses Units, 20-21 Boulevard Jean Moulin, 13005 Marseille |
| Organization | French National Blood Service (EFS) |
| Collaborations | |
| Funding | |
| Funding status |
Public |
| Details | ANR funding |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | French National Blood Service (EFS) |
| Organisation status |
Public |
| Presence of scientific or steering committees |
No |
| Additional contact | |
| Name of the contact | Bonneaudeau |
| Surname | Brigitte |
| brigitte.bonneaudeau@efs.sante.fr | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database objective | |
| Main objective | Estimate the seroprevalence of SARS-CoV-2 infection in the French blood donor population (18-70 years) in different geographical zones (mainland France and overseas departments), at different times in the epidemic, so as to model the progression of the epidemic |
| Inclusion criteria |
Accepted blood donors
aged 18 to 70 years. in the geographical zones of interest having agreed to the use of their samples for research Plasma samples > 500 µL in volume |
| Population type | |
| Age |
Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
| Population covered |
General population |
| Pathology | |
| Gender |
Male Woman |
| Geography area |
National |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2021 |
| Size of the database | |
| Size of the database (number of individuals) |
[10 000-20 000[ individuals |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Biological data Administrative data |
| Presence of a biobank |
Yes |
| Contents of biobank |
Plasma |
| Procedures | |
| Followed pathology | |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362788/ |
| Description | Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Gallian P, Pastorino B, Morel P, Chiaroni J, Ninove L, de Lamballerie X.Antiviral Res. 2020 Sep;181:104880 |
| Access |
